Jiabin Li

541 total citations
30 papers, 367 citations indexed

About

Jiabin Li is a scholar working on Epidemiology, Molecular Medicine and Infectious Diseases. According to data from OpenAlex, Jiabin Li has authored 30 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Epidemiology, 13 papers in Molecular Medicine and 6 papers in Infectious Diseases. Recurrent topics in Jiabin Li's work include Antibiotic Resistance in Bacteria (13 papers), Hepatitis B Virus Studies (7 papers) and Immune Cell Function and Interaction (5 papers). Jiabin Li is often cited by papers focused on Antibiotic Resistance in Bacteria (13 papers), Hepatitis B Virus Studies (7 papers) and Immune Cell Function and Interaction (5 papers). Jiabin Li collaborates with scholars based in China, United Kingdom and Belgium. Jiabin Li's co-authors include Ying Ye, Yanyan Liu, Chen Liu, Zhou Liu, Yi Gu, Ming Sun, Xin Li, Na Lv, Lifen Hu and Rui Sun and has published in prestigious journals such as PLoS ONE, Scientific Reports and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Jiabin Li

27 papers receiving 362 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiabin Li China 11 149 95 92 91 58 30 367
Noha A. Hassuna Egypt 10 218 1.5× 115 1.2× 82 0.9× 122 1.3× 32 0.6× 40 389
Hadi Peeridogaheh Iran 13 109 0.7× 95 1.0× 27 0.3× 141 1.5× 31 0.5× 30 406
Reem Hassan Egypt 12 152 1.0× 87 0.9× 76 0.8× 75 0.8× 16 0.3× 33 347
Borui Pi China 11 217 1.5× 57 0.6× 92 1.0× 167 1.8× 7 0.1× 14 445
Mingzhe Ning China 11 204 1.4× 62 0.7× 111 1.2× 140 1.5× 14 0.2× 22 391
Wangxiao Zhou China 12 125 0.8× 58 0.6× 57 0.6× 140 1.5× 34 0.6× 31 345
Gabriella Piatti Italy 13 103 0.7× 96 1.0× 90 1.0× 130 1.4× 23 0.4× 34 426
Huifen Ye China 11 203 1.4× 76 0.8× 85 0.9× 210 2.3× 17 0.3× 26 510
Nuran Yuluğ Türkiye 11 84 0.6× 143 1.5× 23 0.3× 100 1.1× 10 0.2× 47 469
Dietmar Fernández‐Orth Spain 12 146 1.0× 77 0.8× 88 1.0× 200 2.2× 40 0.7× 19 452

Countries citing papers authored by Jiabin Li

Since Specialization
Citations

This map shows the geographic impact of Jiabin Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiabin Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiabin Li more than expected).

Fields of papers citing papers by Jiabin Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiabin Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiabin Li. The network helps show where Jiabin Li may publish in the future.

Co-authorship network of co-authors of Jiabin Li

This figure shows the co-authorship network connecting the top 25 collaborators of Jiabin Li. A scholar is included among the top collaborators of Jiabin Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiabin Li. Jiabin Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Ning, Lingrui Liu, Xiangyang Li, et al.. (2025). Synergistic efficacy of polymyxin B and indole-3-carbinol against Klebsiella pneumoniae bloodstream infection. Microbial Pathogenesis. 208. 108007–108007. 1 indexed citations
2.
Liu, Mengyu, Yuyao Li, Jiajia Li, et al.. (2025). Alterations in the intestinal fungal microbiome of patients with severe fever with thrombocytopenia syndrome. Journal of Infection and Public Health. 18(9). 102837–102837.
3.
Chen, Jie, et al.. (2025). β-Nicotinamide mononucleotide protects against hypervirulent Klebsiella pneumoniae bloodstream infection and liver injury. mSphere. 10(8). e0036125–e0036125. 1 indexed citations
4.
5.
Tian, Ping, Qingqing Li, Yi Yan Yang, et al.. (2024). Zidovudine in synergistic combination with nitrofurantoin or omadacycline: in vitro and in murine urinary tract or lung infection evaluation against multidrug-resistant Klebsiella pneumoniae. Antimicrobial Agents and Chemotherapy. 68(10). e0034424–e0034424. 2 indexed citations
6.
Kan, Lili, et al.. (2024). Thermal impacts on eco-friendly ultra-lightweight high ductility geopolymer composites doped with low fiber volume. Construction and Building Materials. 458. 139607–139607. 8 indexed citations
7.
Tian, Ping, Qingqing Li, Xufeng Li, et al.. (2024). Discovery of clinical isolation of drug-resistant Klebsiella pneumoniae with overexpression of OqxB efflux pump as the decisive drug resistance factor. Microbiology Spectrum. 12(10). e0012224–e0012224. 1 indexed citations
8.
Zhang, Li, et al.. (2022). The Anti-Virulence Effect of Sub-Minimal Inhibitory Concentrations of Levofloxacin on Hypervirulent Klebsiella pneumoniae. Infection and Drug Resistance. Volume 15. 3513–3522. 6 indexed citations
10.
Fu, Binqing, Dongyao Wang, Xiaokun Shen, et al.. (2020). Immunomodulation Induced During Interferon-α Therapy Impairs the Anti-HBV Immune Response Through CD24+CD38hi B Cells. Frontiers in Immunology. 11. 591269–591269. 12 indexed citations
11.
Li, Wenting, Xiaokun Shen, Binqing Fu, et al.. (2017). KIR3DS1/HLA-B Bw4-80Ile Genotype Is Correlated with the IFN-α Therapy Response in hepatitis B e antigen-Positive Chronic Hepatitis B. Frontiers in Immunology. 8. 1285–1285. 8 indexed citations
12.
Lv, Na, Ming Sun, Chen Liu, & Jiabin Li. (2017). Design and synthesis of 2-phenylpyrimidine coumarin derivatives as anticancer agents. Bioorganic & Medicinal Chemistry Letters. 27(19). 4578–4581. 38 indexed citations
13.
Guo, Chuang, Xiaokun Shen, Binqing Fu, et al.. (2016). CD3brightCD56+ T cells associate with pegylated interferon-alpha treatment nonresponse in chronic hepatitis B patients. Scientific Reports. 6(1). 25567–25567. 7 indexed citations
14.
Li, Young, Yang Wu, Xiaohu Zheng, et al.. (2016). Cytoplasm-Translocated Ku70/80 Complex Sensing of HBV DNA Induces Hepatitis-Associated Chemokine Secretion. Frontiers in Immunology. 7. 569–569. 30 indexed citations
15.
Hu, Lifen, Guosheng Chen, Liping Gao, et al.. (2016). Increase in the Prevalence of Resistance Determinants to Trimethoprim/Sulfamethoxazole in Clinical Stenotrophomonas maltophilia Isolates in China. PLoS ONE. 11(6). e0157693–e0157693. 53 indexed citations
16.
Shen, Xiaokun, Binqing Fu, Yanyan Liu, et al.. (2016). NKp30+ NK cells are associated with HBV control during pegylated-interferon-alpha-2b therapy of chronic hepatitis B. Scientific Reports. 6(1). 38778–38778. 14 indexed citations
17.
Yang, Haifei, et al.. (2015). Stool vs. Serum Hepatitis B Virus DNA in Patients with Chronic Hepatitis B. Medical Science Monitor. 21. 3840–3846. 3 indexed citations
18.
Mei, Qing, et al.. (2014). Testing the mutant selection window hypothesis in vitro and in vivo with Staphylococcus aureus exposed to fosfomycin. European Journal of Clinical Microbiology & Infectious Diseases. 34(4). 737–744. 15 indexed citations
19.
Ma, Tai, Yuanyuan Li, Jie Zhu, et al.. (2013). Enhanced autophagic flux by endoplasmic reticulum stress in human hepatocellular carcinoma cells contributes to the maintenance of cell viability. Oncology Reports. 30(1). 433–440. 7 indexed citations
20.
Ye, Ying, et al.. (2010). Emergence of CTX-M-3, TEM-1 and a new plasmid-mediated MOX-4 AmpC in a multiresistant Aeromonas caviae isolate from a patient with pneumonia. Journal of Medical Microbiology. 59(7). 843–847. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026